SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about allotment under ESOP

14 Aug 2024 Evaluate
Mankind Pharma has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution passed today, August 14, 2024, has allotted 9,000 equity shares of face value of Re 1 each of the Company to the eligible employees who have exercised their options pursuant to Employees Stock Option Plan 2022 (ESOP 2022).

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2143.60 20.40 (0.96%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×